Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.19 +0.00 (+0.00%)
As of: Oct 5, 2026 · 3:45 PM EDT

Drugs Made In America Acquisition (DMII) Retained Earnings (2024 - 2026)

Updated

Drugs Made In America Acquisition (DMII) recorded Retained Earnings of -$17.93 million in Q2 2026.

Analysis

Drugs Made In America Acquisition (DMII) Retained Earnings (2024 - 2026) Analysis & Trends

At the end of FY2025, Drugs Made In America Acquisition reported Retained Earnings of -$17.78 million.

  • Across earlier years, Retained Earnings came in at -$151,719 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 BlackRock 164.13 Bn 110.49 Bn - 40.21 Bn
2 Spdr Gold Trust 133.82 Bn -424.18 Bn - -
3 Blackstone 84.08 Bn 79.01 Bn - -18.65 Mn
4 Brookfield 82.97 Bn -82.41 Bn 4.47 Bn 5.65 Bn
5 Kkr 81.05 Bn 47.53 Bn - 14.57 Bn
6 Brookfield Asset Management 71.64 Bn 67.88 Bn - -950.00 Mn
7 Apollo Global Management 65.67 Bn 3.35 Bn 10.56 Bn 6.15 Bn
8 Wheaton Precious Metals 61.89 Bn 57.32 Bn 687.86 Mn 5.78 Bn
9 Franco Nevada 46.13 Bn 43.49 Bn 451.00 Mn 2.05 Bn
10 Drugs Made In America Acquisition 649.10 Mn 649.10 Mn - -17.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.93 Mn
Dec 31, 2025 -17.78 Mn
Sep 30, 2025 -17.28 Mn
Dec 31, 2024 -151,719.00
API Access

Drugs Made In America Acquisition Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=DMII&period=max&api_key=YOUR_API_KEY